Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response-Reference-Cited by-同舟云学术

Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response

Published:2021-04-30 Issue:5 Volume:84 Page:472-477
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Hsieh Yun-Cheng,Lee Kuei-Chuan,Su Chien-Wei,Lan Ken-Hsin,Huo Teh-Ia,Wang Yuan-Jen,Huang Hui-Chun,Lin Han-Chieh,Chu Chi-Jen,Huang Yi-Hsiang,Hou Ming-Chih

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference24 articles.

1. Regression of hepatic fibrosis and cirrhosis in patients with chronic hepatitis C treated with interferon-based therapy.;Metwally;Gastroenterology,2003

2. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.;van der Meer;JAMA,2012

3. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.;El-Kamary;Clin Infect Dis,2011

4. Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis.;Majumdar;Aliment Pharmacol Ther,2016

5. Hepatitis C guidance 2019 update: American association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection.;Ghany;Hepatology,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients;Scientific Reports;2024-03-29

2. Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR;Journal of Viral Hepatitis;2022-11-02

3. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy;Scientific Reports;2022-03-09